首页 | 本学科首页   官方微博 | 高级检索  
     


Analysis of the immune reactivity of infiltrating and peripheral lymphocytes from patients with renal cell carcinoma by measuring cytokine secretion
Authors:Ursula Elsässer-Beile  Ulrich Wetterauer  Wolfgang Schultze-Seemann  Harald Gallati  Jürgen Schulte Mönting  Sabine von Kleist
Affiliation:(1) Urological Department, University of Freiburg, D-79106 Freiburg, Germany, DE;(2) Hoffmann-La Roche, CH-4002 Basel, Switzerland, CH;(3) Institute of Medical Biometry, University of Freiburg, D-79104 Freiburg, Germany, DE;(4) Institute of Immunobiology, University of Freiburg, Medical Faculty, D-79104 Freiburg, Germany, DE;(5) Institute of Immunobiology, University of Freiburg, Stefan-Meier-Str. 8, D-79104 Freiburg, Germany Fax: 203 5446, DE
Abstract: The immunological properties of tumor-infiltrating (TIL) and peripheral blood lymphocytes (PBL) from 29 patients with renal cell carcinomas were characterized with respect to their phenotypic expression and cytokine production. TIL were isolated from mechanically disaggregated tumor material and PBL from peripheral blood by gradient centrifugation. To eliminate all non-lymphoid cells, CD3-positive cells were specifically separated from these cell fractions with anti-CD3 magnetic beads. These pure CD3-positive PBL (CD3+PBL) and TIL (CD3+TIL) were cultured with pokeweed mitogen and the levels of the cytokines interleukin-1α (IL-1α), IL-1β, IL-2, interferon γ (IFNγ), and tumor necrosis factor α (TNFα) measured in the 4-day post-inductional cell culture supernatants. In all cell cultures a wide range of cytokine values was found, indicating a large variation in the immunological activity of the lymphocytes of each individual. When the cell cultures of the CD3+TIL and CD3+PBL were compared in each patient similar values for IL-1α, IL-1β, IFNγ and TNFα were found. However CD3+TIL produced significantly lower levels of IL-2 than CD3+PBL upon mitogenic stimulation. This may be due to a lower CD4/CD8 ratio in the CD3+TIL as compared to the CD3+PBL. These results suggest that there are no fundamental qualitative and quantitative differences in the lymphokine-producing capacity of CD3+TIL and CD3+PBL derived from patients with renal cell carcinomas. Received: 8 August 1995 / Accepted: 23 January 1996
Keywords:  Renal cell carcinoma  PBL  TIL  Cytokine production
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号